Dupilumab, a Novel Treatment for Peripheral Neuropathy: A Case Series

Peripheral neuropathy is a chronic neurological disorder that can present with a multitude of symptoms. It is observed in association with various disease states and organ systems. In the process of treatment for atopic dermatitis, we have observed that patients reported improvements in their previously diagnosed neuropathies, essentially, relief from neuropathic symptoms such as burning, itching, or tingling. On the basis of these observations, we conducted a single-arm trial to survey the qualitative changes in patients with peripheral neuropathy. Ten patients with atopic dermatitis with previously diagnosed peripheral neuropathies were treated with dupilumab (DP) and observed for symptom changes over 6 months. A paired t-test was used to determine whether DP might potentially be used as an off-label treatment for patients with peripheral neuropathy and dermatological conditions. Our patients showed significant symptom relief, thus suggesting that further investigation of the use of DP for patients with neuropathies is warranted.

Authors

Institutions

Publication Details

Journal
Dermatology and Therapy
Published
2025-04-24
DOI
https://doi.org/10.1007/s13555-025-01415-0
Citations
1
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
2.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dupilumab, a Novel Treatment for Peripheral Neuropathy: A Case Series

Sunny B Patel, D. Roy, Michael H. Coffin, Bart W B Sweers
1 citations
Dermatology and Therapy
Dermatology and Skin Diseases
2.00
article

Dupilumab, a Novel Treatment for Peripheral Neuropathy: A Case Series

Sunny B Patel, D. Roy, Michael H. Coffin, Bart W B Sweers
article en
1 citations

Abstract

Peripheral neuropathy is a chronic neurological disorder that can present with a multitude of symptoms. It is observed in association with various disease states and organ systems. In the process of treatment for atopic dermatitis, we have observed that patients reported improvements in their previously diagnosed neuropathies, essentially, relief from neuropathic symptoms such as burning, itching, or tingling. On the basis of these observations, we conducted a single-arm trial to survey the qualitative changes in patients with peripheral neuropathy. Ten patients with atopic dermatitis with previously diagnosed peripheral neuropathies were treated with dupilumab (DP) and observed for symptom changes over 6 months. A paired t-test was used to determine whether DP might potentially be used as an off-label treatment for patients with peripheral neuropathy and dermatological conditions. Our patients showed significant symptom relief, thus suggesting that further investigation of the use of DP for patients with neuropathies is warranted.

Dermatology and TherapyVol. 15(6)
Radboud University Nijmegen (NL), William Carey University (US), University Medical Center (US), Radboud University Medical Center (NL)
Openalex Percentile: Top 16%
Dermatology and Skin Diseases
2.00
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.